The alterations in peripheral lymphocyte subsets predict the efficacy and prognosis of immune checkpoint inhibitors in hepatocellular carcinoma

Background: Immune checkpoint inhibitor (ICI) treatments are promising therapies for hepatocellular carcinoma (HCC) patients. However, not all HCC patients benefit from immunotherapy. Therefore, it is urgent to explore markers for the clinical efficacy and prognosis of immunotherapy for liver cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Qu, Hu, Can, Luo, Cong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539567/
https://www.ncbi.nlm.nih.gov/pubmed/37781071
http://dx.doi.org/10.7150/jca.88101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539567/
https://www.ncbi.nlm.nih.gov/pubmed/37781071
http://dx.doi.org/10.7150/jca.88101

Ejemplares similares